EMEA (Europe, Middle East and Africa) Tigecycline Market Report 2017

November 2017 | 113 pages | ID: E7090F5CD14EN
QYResearch

Abstracts

In this report, the EMEA Tigecycline market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Tigecycline for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Tigecycline market competition by top manufacturers/players, with Tigecycline sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Hisun Pharma
• Hansoh Pharma
• Jiagsu Aosaikang Pharmaceutical
• HICIN Pharma
• Abbott Laboratories
• Amgen
• Astrazeneca
• Merck
• Novartis
• Roche Holdings
• Johnson & Johnson
• Sanofi
• Lifecare Innovations
• Progen Nutraceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Gram Positive Bacteria
• Gram Negative Bacteria

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Skin & Soft Tissue Infections
• Complicated Intra-abdominal Infections
• Community-acquired Bacterial Pneumonia

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Tigecycline Market Report 2017

1 TIGECYCLINE OVERVIEW

1.1 Product Overview and Scope of Tigecycline
1.2 Classification of Tigecycline
  1.2.1 EMEA Tigecycline Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Tigecycline Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Gram Positive Bacteria
  1.2.4 Gram Negative Bacteria
1.3 EMEA Tigecycline Market by Application/End Users
  1.3.1 EMEA Tigecycline Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Skin & Soft Tissue Infections
  1.3.3 Complicated Intra-abdominal Infections
  1.3.4 Community-acquired Bacterial Pneumonia
1.4 EMEA Tigecycline Market by Region
  1.4.1 EMEA Tigecycline Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Tigecycline (2012-2022)
  1.5.1 EMEA Tigecycline Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Tigecycline Revenue and Growth Rate (2012-2022)

2 EMEA TIGECYCLINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Tigecycline Market Competition by Players/Manufacturers
  2.1.1 EMEA Tigecycline Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Tigecycline Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Tigecycline Sale Price by Players (2012-2017)
2.2 EMEA Tigecycline (Volume and Value) by Type/Product Category
  2.2.1 EMEA Tigecycline Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Tigecycline Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Tigecycline Sale Price by Type (2012-2017)
2.3 EMEA Tigecycline (Volume) by Application
2.4 EMEA Tigecycline (Volume and Value) by Region
  2.4.1 EMEA Tigecycline Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Tigecycline Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Tigecycline Sales Price by Region (2012-2017)

3 EUROPE TIGECYCLINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Tigecycline Sales and Value (2012-2017)
  3.1.1 Europe Tigecycline Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Tigecycline Revenue and Growth Rate (2012-2017)
3.2 Europe Tigecycline Sales and Market Share by Type
3.3 Europe Tigecycline Sales and Market Share by Application
3.4 Europe Tigecycline Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Tigecycline Sales Volume by Countries (2012-2017)
  3.4.2 Europe Tigecycline Revenue by Countries (2012-2017)
  3.4.3 Germany Tigecycline Sales and Growth Rate (2012-2017)
  3.4.4 France Tigecycline Sales and Growth Rate (2012-2017)
  3.4.5 UK Tigecycline Sales and Growth Rate (2012-2017)
  3.4.6 Russia Tigecycline Sales and Growth Rate (2012-2017)
  3.4.7 Italy Tigecycline Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Tigecycline Sales and Growth Rate (2012-2017)

4 MIDDLE EAST TIGECYCLINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Tigecycline Sales and Value (2012-2017)
  4.1.1 Middle East Tigecycline Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Tigecycline Revenue and Growth Rate (2012-2017)
4.2 Middle East Tigecycline Sales and Market Share by Type
4.3 Middle East Tigecycline Sales and Market Share by Application
4.4 Middle East Tigecycline Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Tigecycline Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Tigecycline Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Tigecycline Sales and Growth Rate (2012-2017)
  4.4.4 Israel Tigecycline Sales and Growth Rate (2012-2017)
  4.4.5 UAE Tigecycline Sales and Growth Rate (2012-2017)
  4.4.6 Iran Tigecycline Sales and Growth Rate (2012-2017)

5 AFRICA TIGECYCLINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Tigecycline Sales and Value (2012-2017)
  5.1.1 Africa Tigecycline Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Tigecycline Revenue and Growth Rate (2012-2017)
5.2 Africa Tigecycline Sales and Market Share by Type
5.3 Africa Tigecycline Sales and Market Share by Application
5.4 Africa Tigecycline Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Tigecycline Sales Volume by Countries (2012-2017)
  5.4.2 Africa Tigecycline Revenue by Countries (2012-2017)
  5.4.3 South Africa Tigecycline Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Tigecycline Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Tigecycline Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Tigecycline Sales and Growth Rate (2012-2017)

6 EMEA TIGECYCLINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Tigecycline Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Hisun Pharma
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Tigecycline Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Hisun Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Hansoh Pharma
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Tigecycline Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Hansoh Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Jiagsu Aosaikang Pharmaceutical
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Tigecycline Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Jiagsu Aosaikang Pharmaceutical Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 HICIN Pharma
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Tigecycline Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 HICIN Pharma Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Abbott Laboratories
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Tigecycline Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Abbott Laboratories Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Amgen
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Tigecycline Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Amgen Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Astrazeneca
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Tigecycline Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Astrazeneca Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Merck
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Tigecycline Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Merck Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Novartis
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Tigecycline Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis Tigecycline Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Roche Holdings
6.12 Johnson & Johnson
6.13 Sanofi
6.14 Lifecare Innovations
6.15 Progen Nutraceuticals

7 TIGECYCLINE MANUFACTURING COST ANALYSIS

7.1 Tigecycline Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Tigecycline

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Tigecycline Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Tigecycline Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA TIGECYCLINE MARKET FORECAST (2017-2022)

11.1 EMEA Tigecycline Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Tigecycline Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Tigecycline Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Tigecycline Price and Trend Forecast (2017-2022)
11.2 EMEA Tigecycline Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Tigecycline Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Tigecycline Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Tigecycline Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Tigecycline Sales Forecast by Type (2017-2022)
11.7 EMEA Tigecycline Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Tigecycline
Figure EMEA Tigecycline Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Tigecycline Sales Volume Market Share by Type (Product Category) in 2016
Figure Gram Positive Bacteria Product Picture
Figure Gram Negative Bacteria Product Picture
Figure EMEA Tigecycline Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Tigecycline by Application in 2016
Figure Skin & Soft Tissue Infections Examples
Table Key Downstream Customer in Skin & Soft Tissue Infections
Figure Complicated Intra-abdominal Infections Examples
Table Key Downstream Customer in Complicated Intra-abdominal Infections
Figure Community-acquired Bacterial Pneumonia Examples
Table Key Downstream Customer in Community-acquired Bacterial Pneumonia
Figure EMEA Tigecycline Market Size (Million USD) by Region (2012-2022)
Figure Europe Tigecycline Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Tigecycline Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Tigecycline Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Tigecycline Revenue (Million USD) Status and Forecast by Countries
Figure Africa Tigecycline Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Tigecycline Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Tigecycline Sales Volume and Growth Rate (2012-2022)
Figure EMEA Tigecycline Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Tigecycline Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Tigecycline Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Tigecycline Sales Share by Players (2012-2017)
Figure 2016 Tigecycline Sales Share by Players
Figure 2017 Tigecycline Sales Share by Players
Figure EMEA Tigecycline Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Tigecycline Revenue (Million USD) by Players (2012-2017)
Table EMEA Tigecycline Revenue Share by Players (2012-2017)
Table 2016 EMEA Tigecycline Revenue Share by Players
Table 2017 EMEA Tigecycline Revenue Share by Players
Table EMEA Tigecycline Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Tigecycline Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Tigecycline Sales Share by Type (2012-2017)
Figure Sales Market Share of Tigecycline by Type (2012-2017)
Figure EMEA Tigecycline Sales Market Share by Type (2012-2017)
Table EMEA Tigecycline Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Tigecycline Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Tigecycline by Type in 2016
Table EMEA Tigecycline Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Tigecycline Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Tigecycline Sales Share by Application (2012-2017)
Figure Sales Market Share of Tigecycline by Application (2012-2017)
Figure EMEA Tigecycline Sales Market Share by Application in 2016
Table EMEA Tigecycline Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Tigecycline Sales Share by Region (2012-2017)
Figure Sales Market Share of Tigecycline by Region (2012-2017)
Figure EMEA Tigecycline Sales Market Share in 2016
Table EMEA Tigecycline Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Tigecycline Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Tigecycline by Region (2012-2017)
Figure EMEA Tigecycline Revenue Market Share Regions in 2016
Table EMEA Tigecycline Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Tigecycline Revenue and Growth Rate (2012-2017)
Table Europe Tigecycline Sales (K Pcs) by Type (2012-2017)
Table Europe Tigecycline Market Share by Type (2012-2017)
Figure Europe Tigecycline Market Share by Type in 2016
Table Europe Tigecycline Sales (K Pcs) by Application (2012-2017)
Table Europe Tigecycline Market Share by Application (2012-2017)
Figure Europe Tigecycline Market Share by Application in 2016
Table Europe Tigecycline Sales (K Pcs) by Countries (2012-2017)
Table Europe Tigecycline Sales Market Share by Countries (2012-2017)
Figure Europe Tigecycline Sales Market Share by Countries (2012-2017)
Figure Europe Tigecycline Sales Market Share by Countries in 2016
Table Europe Tigecycline Revenue (Million USD) by Countries (2012-2017)
Table Europe Tigecycline Revenue Market Share by Countries (2012-2017)
Figure Europe Tigecycline Revenue Market Share by Countries (2012-2017)
Figure Europe Tigecycline Revenue Market Share by Countries in 2016
Figure Germany Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Tigecycline Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Tigecycline Sales (K Pcs) by Type (2012-2017)
Table Middle East Tigecycline Market Share by Type (2012-2017)
Figure Middle East Tigecycline Market Share by Type (2012-2017)
Table Middle East Tigecycline Sales (K Pcs) by Applications (2012-2017)
Table Middle East Tigecycline Market Share by Applications (2012-2017)
Figure Middle East Tigecycline Sales Market Share by Application in 2016
Table Middle East Tigecycline Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Tigecycline Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Tigecycline Sales Volume Market Share by Countries in 2016
Table Middle East Tigecycline Revenue (Million USD) by Countries (2012-2017)
Table Middle East Tigecycline Revenue Market Share by Countries (2012-2017)
Figure Middle East Tigecycline Revenue Market Share by Countries (2012-2017)
Figure Middle East Tigecycline Revenue Market Share by Countries in 2016
Figure Saudi Arabia Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Tigecycline Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Tigecycline Sales (K Pcs) by Type (2012-2017)
Table Africa Tigecycline Sales Market Share by Type (2012-2017)
Figure Africa Tigecycline Sales Market Share by Type (2012-2017)
Figure Africa Tigecycline Sales Market Share by Type in 2016
Table Africa Tigecycline Sales (K Pcs) by Application (2012-2017)
Table Africa Tigecycline Sales Market Share by Application (2012-2017)
Figure Africa Tigecycline Sales Market Share by Application (2012-2017)
Table Africa Tigecycline Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Tigecycline Sales Market Share by Countries (2012-2017)
Figure Africa Tigecycline Sales Market Share by Countries (2012-2017)
Figure Africa Tigecycline Sales Market Share by Countries in 2016
Table Africa Tigecycline Revenue (Million USD) by Countries (2012-2017)
Table Africa Tigecycline Revenue Market Share by Countries (2012-2017)
Figure Africa Tigecycline Revenue Market Share by Countries (2012-2017)
Figure Africa Tigecycline Revenue Market Share by Countries in 2016
Figure South Africa Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Table Pfizer Tigecycline Basic Information List
Table Pfizer Tigecycline Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Tigecycline Sales Market Share in EMEA (2012-2017)
Figure Pfizer Tigecycline Revenue Market Share in EMEA (2012-2017)
Table Hisun Pharma Tigecycline Basic Information List
Table Hisun Pharma Tigecycline Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hisun Pharma Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Hisun Pharma Tigecycline Sales Market Share in EMEA (2012-2017)
Figure Hisun Pharma Tigecycline Revenue Market Share in EMEA (2012-2017)
Table Hansoh Pharma Tigecycline Basic Information List
Table Hansoh Pharma Tigecycline Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hansoh Pharma Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Hansoh Pharma Tigecycline Sales Market Share in EMEA (2012-2017)
Figure Hansoh Pharma Tigecycline Revenue Market Share in EMEA (2012-2017)
Table Jiagsu Aosaikang Pharmaceutical Tigecycline Basic Information List
Table Jiagsu Aosaikang Pharmaceutical Tigecycline Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Jiagsu Aosaikang Pharmaceutical Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Jiagsu Aosaikang Pharmaceutical Tigecycline Sales Market Share in EMEA (2012-2017)
Figure Jiagsu Aosaikang Pharmaceutical Tigecycline Revenue Market Share in EMEA (2012-2017)
Table HICIN Pharma Tigecycline Basic Information List
Table HICIN Pharma Tigecycline Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure HICIN Pharma Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure HICIN Pharma Tigecycline Sales Market Share in EMEA (2012-2017)
Figure HICIN Pharma Tigecycline Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Tigecycline Basic Information List
Table Abbott Laboratories Tigecycline Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abbott Laboratories Tigecycline Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Tigecycline Revenue Market Share in EMEA (2012-2017)
Table Amgen Tigecycline Basic Information List
Table Amgen Tigecycline Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amgen Tigecycline Sales Market Share in EMEA (2012-2017)
Figure Amgen Tigecycline Revenue Market Share in EMEA (2012-2017)
Table Astrazeneca Tigecycline Basic Information List
Table Astrazeneca Tigecycline Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astrazeneca Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Astrazeneca Tigecycline Sales Market Share in EMEA (2012-2017)
Figure Astrazeneca Tigecycline Revenue Market Share in EMEA (2012-2017)
Table Merck Tigecycline Basic Information List
Table Merck Tigecycline Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck Tigecycline Sales Market Share in EMEA (2012-2017)
Figure Merck Tigecycline Revenue Market Share in EMEA (2012-2017)
Table Novartis Tigecycline Basic Information List
Table Novartis Tigecycline Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Tigecycline Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis Tigecycline Sales Market Share in EMEA (2012-2017)
Figure Novartis Tigecycline Revenue Market Share in EMEA (2012-2017)
Table Roche Holdings Tigecycline Basic Information List
Table Johnson & Johnson Tigecycline Basic Information List
Table Sanofi Tigecycline Basic Information List
Table Lifecare Innovations Tigecycline Basic Information List
Table Progen Nutraceuticals Tigecycline Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Tigecycline
Figure Manufacturing Process Analysis of Tigecycline
Figure Tigecycline Industrial Chain Analysis
Table Raw Materials Sources of Tigecycline Major Manufacturers in 2016
Table Major Buyers of Tigecycline
Table Distributors/Traders List
Figure EMEA Tigecycline Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Tigecycline Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Tigecycline Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Tigecycline Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Tigecycline Sales Market Share Forecast by Region (2017-2022)
Table EMEA Tigecycline Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Tigecycline Revenue Market Share Forecast by Region (2017-2022)
Table Europe Tigecycline Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Tigecycline Sales Market Share Forecast by Countries (2017-2022)
Table Europe Tigecycline Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Tigecycline Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Tigecycline Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Tigecycline Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Tigecycline Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Tigecycline Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Tigecycline Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Tigecycline Sales Market Share Forecast by Countries (2017-2022)
Table Africa Tigecycline Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Tigecycline Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Tigecycline Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Tigecycline Sales Market Share Forecast by Type (2017-2022)
Table EMEA Tigecycline Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Tigecycline Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources